Craig Andrew Miller

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Craig Andrew Miller. Retrieved from https://idiyas.com/inventor/craig-andrew-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 7.6

ph-index = 2

Forward Citations = 34(Granted Patents)

Location History:

Danbury, CT (US) (2007)
Ridgefield, CT (US) (2009)
Mt. Vernon, NY (US) (2010)
Mount Vernon, NY (US) (2013)
Norwalk, CT (US) (2013 - 2014)
New Milford, CT (US) (2018 - 2021)

Company Filing History:

8 out of 1,562

Boehringer Ingelheim International Gmbh

patents

3 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

Years Active: 2007-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12139484 - Substituted benzamides as RIPK2 inhibitors for treatment of inflammatory bowel disease (2024-11-12),

2. 11130754 - Substituted benzamides as RIPK2 inhibitors (2021-09-28),

3. 10138241 - Substituted benzamides as RIPK2 inhibitors (2018-11-27),

4. 10138222 - Substituted benzamides as RIPK2 inhibitors (2018-11-27),

5. 8859814 - [object Object] (2014-10-14),

6. 8586748 - 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 (2013-11-19),

7. 8575360 - [object Object] (2013-11-05),

8. 8552205 - Derivatives of 6,7-dihydro-5H-imidazo[1,2-alpha]imidazole-3-carboxylic acid amides (2013-10-08),

9. 7790712 - Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors (2010-09-07),

10. 7514458 - Anti-cytokine heterocyclic compounds (2009-04-07),

11. 7214802 - Anti-cytokine heterocyclic compounds (2007-05-08),

Title: Craig Andrew Miller - Pioneering Inventor from Norwalk

Introduction: Craig Andrew Miller is a distinguished inventor hailing from Norwalk, CT. His innovative spirit and dedication to creating groundbreaking solutions have solidified his reputation in the world of patents and inventions.

Latest Patents: Craig Andrew Miller holds several patents in various fields, including technology, healthcare, and consumer products. His recent patents showcase his versatility and forward-thinking approach to problem-solving.

Career Highlights: Throughout his illustrious career, Craig Andrew Miller has consistently pushed the boundaries of innovation. His contributions have not only improved existing technologies but have also paved the way for new advancements in the industry.

Collaborations: Craig Andrew Miller has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Craig Andrew Miller's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His work continues to inspire future generations to think creatively and push the limits of what is possible.

Profile summary based on public USPTO records.